Sotera Health (SHC) Gets a Buy from Barclays
TipRanks (Wed, 24-Jun 4:26 AM ET)
Market Chameleon (Tue, 12-May 4:00 AM ET)
Sotera Health Announces Secondary Offering of Common Stock
Globe Newswire (Mon, 11-May 4:33 PM ET)
Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
Globe Newswire (Tue, 5-May 7:03 AM ET)
Sotera Health Announces Leadership Transition
Globe Newswire (Tue, 5-May 7:00 AM ET)
Sotera Health Announces First-Quarter 2026 Earnings Release Date
Globe Newswire (Tue, 21-Apr 7:46 AM ET)
Sotera Health Launches 25 Million Share Secondary Offering—Key Takeaways for Investors
Market Chameleon (Thu, 5-Mar 2:59 AM ET)
Market Chameleon (Fri, 7-Nov 4:03 AM ET)
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
Sotera Health Company trades on the NASDAQ stock market under the symbol SHC.
As of June 26, 2026, SHC stock price climbed to $17.22 with 689,183 million shares trading.
SHC has a beta of 2.07, meaning it tends to be more sensitive to market movements. SHC has a correlation of 0.34 to the broad based SPY ETF.
SHC has a market cap of $4.90 billion. This is considered a Mid Cap stock.
Last quarter Sotera Health Company reported $280 million in Revenue and $.18 earnings per share. This beat revenue expectation by $9 million and exceeded earnings estimates by $.01.
In the last 3 years, SHC traded as high as $19.85 and as low as $9.53.
The top ETF exchange traded funds that SHC belongs to (by Net Assets): IJH, VTI, VB, VBK, VXF.
SHC has outperformed the market in the last year with a price return of +54.6% while the SPY ETF gained +22.3%. SHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +25.7% and +5.1%, respectively, while the SPY returned +12.2% and -0.2%, respectively.
SHC support price is $16.71 and resistance is $17.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SHC shares will trade within this expected range on the day.